Double-Punch cancer therapy tested in major trial
NCT ID NCT04276376
Summary
This trial tested whether combining two existing cancer drugs—rucaparib and atezolizumab—could better control advanced solid tumors. It enrolled 130 adults with specific cancers, like lung or bladder cancer, that had certain genetic repair problems or were sensitive to platinum chemotherapy. The main goal was to see how many patients' tumors shrank or disappeared with this combination treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gustave Roussy
Villejuif, Val De Marne, 94800, France
Conditions
Explore the condition pages connected to this study.